Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
269.37
+3.93 (1.48%)
Mar 27, 2024, 4:00 PM EDT - Market closed
CRL Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for CRL stock have an average target of 252.92, with a low estimate of 203 and a high estimate of 290. The average target predicts a decrease of -6.11% from the current stock price of 269.37.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 2 | 3 |
Buy | 4 | 4 | 4 | 4 | 5 | 5 |
Hold | 4 | 4 | 4 | 4 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 11 | 11 | 11 | 12 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Argus Research | Argus Research | Strong Buy Maintains $240 → $290 | Strong Buy | Maintains | $240 → $290 | +7.66% | Mar 18, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $265 | Buy | Maintains | $260 → $265 | -1.62% | Feb 15, 2024 |
UBS | UBS | Strong Buy Maintains $270 → $290 | Strong Buy | Maintains | $270 → $290 | +7.66% | Feb 15, 2024 |
Citigroup | Citigroup | Hold Maintains $215 → $250 | Hold | Maintains | $215 → $250 | -7.19% | Feb 15, 2024 |
Baird | Baird | Buy Maintains $252 → $268 | Buy | Maintains | $252 → $268 | -0.51% | Feb 15, 2024 |
Financial Forecast
Revenue This Year
4.26B
from 4.13B
Increased by 3.24%
Revenue Next Year
4.58B
from 4.26B
Increased by 7.37%
EPS This Year
11.11
from 9.22
Increased by 20.46%
EPS Next Year
12.52
from 11.11
Increased by 12.76%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.5B | 4.9B | 5.3B | 5.5B | 6.0B |
Avg | 4.3B | 4.6B | 4.9B | 5.3B | 5.8B |
Low | 4.1B | 4.3B | 4.6B | 5.2B | 5.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.0% | 14.6% | 14.7% | 12.5% | 13.7% |
Avg | 3.2% | 7.4% | 7.6% | 8.0% | 9.4% |
Low | -0.3% | 1.3% | -0.4% | 4.7% | 6.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.75 | 13.58 | 15.25 | 18.85 | 21.91 |
Avg | 11.11 | 12.52 | 13.92 | 16.42 | 21.08 |
Low | 10.59 | 11.77 | 12.26 | 15.04 | 20.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 27.4% | 22.2% | 21.8% | 35.4% | 33.5% |
Avg | 20.5% | 12.8% | 11.1% | 18.0% | 28.4% |
Low | 14.9% | 6.0% | -2.1% | 8.1% | 24.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.